Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD); (OTCQB: DVHGF), a clinical stage corporation focused on ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options ...

Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with ...

Researchers identified biomarkers related to the Notch signaling pathway that can aid in the diagnosis of IPF.

Chronic obstructive pulmonary disease (COPD) is a prevalent chronic respiratory disease characterized by high prevalence, mortality, and disease burden. Current understanding of COPD pathogenesis ...

This non-promotional AstraZeneca-sponsored symposium intended for healthcare professionals took place on 28 th September 2025 as part of the European Respiratory Society (ERS) Congress held in ...

Background: Dysregulated expression of transcription factors plays a key role in vascular remodeling and the development of pulmonary arterial hypertension (PAH). E2F1 is a central regulator of the ...

Ningbo Key Laboratory of Biomedical Imaging Probe Materials and Technology, CAS Key Laboratory of Magnetic Materials and Devices, Laboratory of Advanced Theranostic Materials and Technology, Ningbo ...

Iron metabolism imbalance and ferroptosis are central to PF pathogenesis, offering new therapeutic targets. Ferroptosis links oxidative stress, iron overload, and fibrotic remodeling, affecting key ...

As patent cliffs approach and new mechanisms gain ground, COPD drugs like HRS-9821 are fast becoming coveted assets. Last month, Hengrui Pharmaceuticals announced a blockbuster licensing deal with GSK ...